Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelopeMaria Castedo, Guido Kroemer, Thomas Roumier et al.|The EMBO Journal|2002Cited by 147
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1Beatriz Mothe, Constanza Lucero, Bonaventura Clotet et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 65
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responsesFerran Tarrés-Freixas, Julià Blanco|npj Vaccines|2023Cited by 34
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated IndividualsBenjamin Trinité, Julià Blanco|Viruses|2021Cited by 20
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and ImmunogenicityRaquel Ortiz, Julià Blanco|International Journal of Molecular Sciences|2023Cited by 11